TY  - CONF
AU  - Carabante-Ocón, F
AU  - Saez-Lara, E
AU  - Burgos-Garcia, L
AU  - Villar-Chamorro, E
AU  - Casaus-Hazañas, A
AU  - Luna, S
AU  - Martínez, C
PY  - 2007
DO  - 10.1186/bcr1708
SN  - 1465-5411
UR  - http://hdl.handle.net/10668/804
T2  - Breast Cancer Research
AB  - Objective: To study the benefit of trastuzumab in monotherapy or combined with different chemotherapeutic agents in the treatment for Her2+ metastatic breast cancer (MBC) patients after progression on prior trastuzumab therapy.
LA  - en
PB  - BioMed Central
KW  - trastuzumab
KW  - her2-positive
KW  - chemotherapies
KW  - MBC
KW  - neoplasias de la mama
KW  - Retratamiento
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Retreatment
TI  - Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
TY  - conference poster
ER  -